Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Classical hematology 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Hematologic Neoplasms 272Leukemia, Myeloid, Acute 255Leukemia 234Lymphoma 127Leukemia, Lymphocytic, Chronic, B-Cell 110Multiple Myeloma 108Neoplasms 95Myelodysplastic Syndromes 95Lymphoma, Non-Hodgkin 94Hodgkin Disease 76Burkitt Lymphoma 64Lymphoma, Mantle-Cell 61Lymphoma, Follicular 60Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Lymphoma, Large B-Cell, Diffuse 56Myeloproliferative Disorders 54Lymphoma, B-Cell, Marginal Zone 53Lymphoma, Large-Cell, Immunoblastic 47Congenital Abnormalities 47Motor Activity 45Leukemia, Myeloid, Chronic-Phase 45Primary Myelofibrosis 43Lymphoma, T-Cell, Cutaneous 43Recurrence 41Sezary Syndrome 39Mycosis Fungoides 39Leukemia, Myeloid, Accelerated Phase 38Neoplasms, Plasma Cell 35Breast Neoplasms 35

Interventions

Transplantation 1Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphopenia × Other hematologic neoplasm × Clear all
NCT01660347 2025-05-02

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

Thomas Jefferson University

Phase NA Withdrawn
Classical hematologyOther hematologic neoplasm

Anemia, Lymphopenia, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡